Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05605340 · ClinicalTrials.gov registry record · NA
Healthier At-home Meals for Expectant Mothers
A NA study of Pregnancy Related and Weight Gain, Maternal, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT05605340: Active NA study of Pregnancy Related and Weight Gain, Maternal, sponsored by University of Alabama at Birmingham.
NCT05605340 is a NA study of Pregnancy Related and Weight Gain, Maternal that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 35 participants, below the 1,963-participant average among 99 other Pregnancy Related trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05605340, a NA study of Pregnancy Related and Weight Gain, Maternal, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to test the feasibility, acceptability, and preliminary efficacy of a meal delivery intervention for managing gestational weight gain among pregnant women with overweight or obesity.
Primary Outcome
Weight measured at each prenatal visit will be retrieved from medical records for all participants and used to model total weight change from the first to the last prenatal visit (i.e., gestational weight gain).
Conditions Studied
Interventions
- BEHAVIORAL Meal Delivery
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2023-08-09 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
What the registry record for NCT05605340 still lists
NCT05605340 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,963-participant average among 99 other Pregnancy Related trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which Meal Delivery is the first listed.
NCT05605340 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05605340 about?
NCT05605340 is a clinical study titled "Healthier At-home Meals for Expectant Mothers". This study is being done to test the feasibility, acceptability, and preliminary efficacy of a meal delivery intervention for managing gestational weight gain among pregnant women with overweight or obesity.
What is the current status of trial NCT05605340?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2023-08-09. Estimated completion is 2026-10-31.
What conditions does trial NCT05605340 study?
This clinical trial studies the following conditions: Pregnancy Related, Weight Gain, Maternal.
What interventions are being tested in trial NCT05605340?
The interventions under investigation include: Meal Delivery (BEHAVIORAL).
Who is sponsoring clinical trial NCT05605340?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05605340 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05605340's enrollment target sits among peer trials
35 87th of 99 higher than 13 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Accountability for Care Through Undoing Racism & Equity for Moms
RECRUITING · NA
-
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
MAMA Tot - Healthy Weight Parallel Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI